标题
XPO1-dependent nuclear export as a target for cancer therapy
作者
关键词
-
出版物
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-03
DOI
10.1186/s13045-020-00903-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer
- (2019) Michael Shafique et al. ONCOLOGIST
- LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease
- (2019) Jie Cui et al. Frontiers in Physiology
- Altered nuclear export signal recognition as a driver of oncogenesis
- (2019) Justin Taylor et al. Cancer Discovery
- STK 38 kinase acts as XPO 1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes
- (2019) Alexandre PJ Martin et al. EMBO REPORTS
- Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
- (2019) Ajai Chari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
- (2019) Yuanhui Liu et al. Journal of Hematology & Oncology
- Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
- (2019) Asfar S. Azmi et al. CLINICAL CANCER RESEARCH
- Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial
- (2018) Weiguo Zhang et al. HAEMATOLOGICA
- Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
- (2018) Dan T. Vogl et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
- (2018) Amy Y. Wang et al. Journal of Hematology & Oncology
- A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer
- (2018) Xiao X. Wei et al. ONCOLOGIST
- CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity
- (2018) David M. Saulino et al. Oncotarget
- Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial
- (2018) Weiguo Zhang et al. HAEMATOLOGICA
- Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled cross-over study.
- (2018) Mrinal M. Gounder et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 study of selinexor plus mitoxantrone, etoposide, and cytarabine in acute myeloid leukemia.
- (2018) Bhavana Bhatnagar et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
- (2018) Vinod Vijay Subhash et al. Scientific Reports
- Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
- (2018) Nizar J. Bahlis et al. BLOOD
- XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy
- (2017) Vincent Camus et al. Journal of Hematology & Oncology
- Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer
- (2017) Arjun Gupta et al. Journal of Thoracic Oncology
- Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1
- (2017) A Cosson et al. LEUKEMIA
- Am I ready for CRISPR? A user's guide to genetic screens
- (2017) John G. Doench NATURE REVIEWS GENETICS
- An Exportin-1–dependent microRNA biogenesis pathway during human cell quiescence
- (2017) Ivan Martinez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A biochemical framework for eIF4E-dependent mRNA export and nuclear recycling of the export machinery
- (2017) Laurent Volpon et al. RNA
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- (2017) Cancer Discovery
- Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
- (2017) Asfar S. Azmi et al. Oncotarget
- CRM1 Inhibitors for Antiviral Therapy
- (2017) Cynthia Mathew et al. Frontiers in Microbiology
- HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells
- (2017) Ranganayaki Muralidharan et al. Scientific Reports
- Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer
- (2016) Ying Chen et al. CLINICAL CANCER RESEARCH
- XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase II to the Nucleus
- (2016) P. Ranganathan et al. CLINICAL CANCER RESEARCH
- Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia
- (2016) Thomas B. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
- (2016) Albiruni R. Abdul Razak et al. JOURNAL OF CLINICAL ONCOLOGY
- KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells
- (2016) J Etchin et al. LEUKEMIA
- XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
- (2016) Jimi Kim et al. NATURE
- Integrated genetic and pharmacologic interrogation of rare cancers
- (2016) Andrew L. Hong et al. Nature Communications
- Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
- (2016) Robert Nakayama et al. Oncotarget
- Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling
- (2016) Hiu-Fung Yuen et al. Oncotarget
- Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia
- (2015) Z. A. Hing et al. BLOOD
- Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas
- (2015) B. Culjkovic-Kraljacic et al. BLOOD
- KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
- (2015) Giovanni Luca Gravina et al. BMC CANCER
- Nuclear transport factors: global regulation of mitosis
- (2015) Douglass J Forbes et al. CURRENT OPINION IN CELL BIOLOGY
- Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice
- (2015) J Etchin et al. LEUKEMIA
- Control of mammalian gene expression by selective mRNA export
- (2015) Vihandha O. Wickramasinghe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185
- (2015) Yoko Tabe et al. PLoS One
- A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning
- (2015) Koray Kırlı et al. eLife
- RNA Export through the NPC in Eukaryotes
- (2015) Masumi Okamura et al. Genes
- Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer
- (2015) Jiankun Gao et al. Oncotarget
- KPT-330 has antitumour activity against non-small cell lung cancer
- (2014) H Sun et al. BRITISH JOURNAL OF CANCER
- KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma
- (2014) Yun Zheng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genome-Wide Association Study: A Useful Tool to Identify Common Genetic Variants Associated with Drug Toxicity and Efficacy in Cancer Pharmacogenomics
- (2014) S.-K. Low et al. CLINICAL CANCER RESEARCH
- Nucleo-cytoplasmic transport as a therapeutic target of cancer
- (2014) Giovanni Luca Gravina et al. Journal of Hematology & Oncology
- CBS9106-Induced CRM1 Degradation Is Mediated by Cullin Ring Ligase Activity and the Neddylation Pathway
- (2014) N. Saito et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma
- (2014) Adam L. Green et al. NEURO-ONCOLOGY
- Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts
- (2014) Shuai Wang et al. PLoS One
- High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells
- (2014) Lesley A. Mathews Griner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biological Significance of the Importin-β Family-Dependent Nucleocytoplasmic Transport Pathways
- (2014) Makoto Kimura et al. TRAFFIC
- Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma
- (2014) JIA-HAO JIANG et al. Oncology Letters
- Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
- (2013) C. J. Walker et al. BLOOD
- Nuclear Export Mediated Regulation of MicroRNAs: Potential Target for Drug Intervention
- (2013) Irfana Muqbil et al. CURRENT DRUG TARGETS
- CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
- (2013) Y-T Tai et al. LEUKEMIA
- Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
- (2013) Qingxiang Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma
- (2012) Kejie Zhang et al. EXPERIMENTAL HEMATOLOGY
- Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis
- (2012) Lior Golomb et al. MOLECULAR CELL
- ValidNESs: a database of validated leucine-rich nuclear export signals
- (2012) Szu-Chin Fu et al. NUCLEIC ACIDS RESEARCH
- CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
- (2011) K. Sakakibara et al. BLOOD
- Comprehensive Identification of Somatic Mutations in Chronic Lymphocytic Leukemia
- (2011) P. Leif Bergsagel et al. CANCER CELL
- Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome
- (2011) R. E. Tiedemann et al. CANCER RESEARCH
- Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
- (2011) H.-F. Yuen et al. CLINICAL CANCER RESEARCH
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Nuclear transport and the mitotic apparatus: an evolving relationship
- (2010) Richard Wozniak et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The nuclear export receptor XPO-1 supports primary miRNA processing in C. elegans and Drosophila
- (2010) Ingo Büssing et al. EMBO JOURNAL
- The Nuclear Pore Complex and Nuclear Transport
- (2010) S. R. Wente et al. Cold Spring Harbor Perspectives in Biology
- A fraction of Crm1 locates at centrosomes by its CRIME domain and regulates the centrosomal localization of pericentrin
- (2009) Qinying Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
- (2009) S. C. Mutka et al. CANCER RESEARCH
- Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP
- (2009) Ivan Topisirovic et al. EMBO JOURNAL
- EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
- (2009) Aiguo Shen et al. NEUROSURGERY
- CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs
- (2009) D. Castanotto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Joining the dots: Production, processing and targeting of U snRNP to nuclear bodies
- (2008) Debra J. Shaw et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Localized RanGTP Accumulation Promotes Microtubule Nucleation at Kinetochores in Somatic Mammalian Cells
- (2008) Liliana Torosantucci et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started